Digest Network Come funziona
Network
/
Società
Or
Non verificato

Orca Bio

Di cosa scriviamo

BiotecnologiaIndustriaMedicina - VarieOncologiaSalute

10 comunicati stampa

Guarda tutti i comunicati
03/11/2025
Scienza
Biotecnologia
Medicina - Varie
Biologia
Salute
Sanità
Oncologia
Eventi
Fiere
Industria
Orca Bio to Present New Clinical Data on Its High-Precision Cell Therapies at the 67th American Society of Hematology Annual Meeting
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
06/10/2025
Oncologia
Salute
Igiene alimentare
Biologia
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Orca Bio Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Orca-T® to Treat Hematological Malignancies
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
04/06/2025
Mercato del lavoro
Biotecnologia
Sanità
Salute
Oncologia
Orca Bio Appoints Key Executives Including Steve Gavel as Chief Commercial Officer
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
12/05/2025
Orca Bio Announces Leadership Updates
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
17/03/2025
Industria
Oncologia
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Orca Bio Announces Positive Results from the Pivotal Phase 3 Study of Investigational Orca-T® Compared to Allogeneic Stem Cell Transplant for the Treatment of Hematologic Malignancies
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
10/02/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Eventi
Fiere
Industria
Orca Bio’s Orca-T® Meets Primary Endpoint in the Pivotal Precision-T Phase 3 Clinical Study for Hematologic Malignancies
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
06/01/2025
Eventi
Oncologia
Salute
Biologia
Biotecnologia
Farmaceutica
Orca Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
09/12/2024
Oncologia
Salute
Biologia
Biotecnologia
Medicina - Varie
Farmaceutica
Eventi
Industria
Orca Bio Presents Three-Year Survival Data with Orca-T® in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
08/12/2024
Eventi
Industria
Scienza
Biotecnologia
Oncologia
Sanità
Salute
Medicina - Varie
Orca Bio Presents Clinical Results on Use of Orca-Q® without GvHD Prophylaxis in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
05/11/2024
Eventi
Fiere
Industria
Scienza
Biotecnologia
Oncologia
Sanità
Salute
Medicina - Varie
Orca Bio to Present Clinical Data on Its High-Precision Cell Therapies at the 66th American Society of Hematology Annual Meeting
Fonte
Orca Bio
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0